NASDAQ: SPRC

Greenlane (Nasdaq:GNLN) Bolsters Global Sales Effort with Appointment of Mike Hinson as Executive Vice President of Sales

Hinson brings a proven track record of driving growth and innovation in sales organizations BOCA RATON, FL / ACCESS Newswire / June 30, 2025 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (Nasdaq:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced the appointment of Mike Hinson as the […]

CISO Global (NASDAQ: CISO) Files Significantly Reduced S-3 Shelf Registration

Reaffirms Commitment to Transparency; No Immediate Plans to Utilize ATM or Shelf Registrations Scottsdale, AZ, June 27, 2025 (GLOBE NEWSWIRE) — CISO Global (NASDAQ: CISO), a leader in AI-powered cybersecurity software and compliance services, announced it has filed the renewal of its S-3 shelf registration, reducing the total shelf from $300 million to $100 million. The […]

Updates FAQ in Response to a High Volume of Shareholder Questions

TRNR details $50M pro forma annual revenue guidance, rationale of expected Sportstech acquisition, comments on market manipulation concerns and bitcoin as a Treasury asset AUSTIN, TX / ACCESS Newswire / February 27, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) (“TRNR” or the “Company”), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today […]

SciSparc (Nasdaq: SPRC) to Acquire AutoMax

TEL AVIV, Israel, April 11, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that it signed a merger agreement (the “Agreement”) with AutoMax Motors Ltd. (“AutoMax”), a leading […]

SciSparc(Nasdaq: SPRC) – Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression

TEL AVIV, Israel, March 27, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of its ongoing collaboration with Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND) (CSE: […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.